Fund Holdings — Lion Point Capital, LP

Total Portfolio Value:
$15.68M
Total Bought:
$518.4K
Total Sold:
$2.40M
Net Transaction:
-$1.88M
Notable People:
Carl Didric Marcus Cederholm
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Insmed Incorporated(INSM)36,70030,500-6,200$2.53M$2.33M14.84%-$206.9K
Ardelyx Inc335,400335,4000$1.70M$1.65M10.51%-$53.7K
Mineralys Therapeutics, Inc.(MLYS)79,00079,0000$972.5K$1.25M8.00%+$282.0K
Fennec Pharmaceuticals Inc.(FENC)195,700195,7000$1.24M$1.19M7.60%-$45.0K
Kiniksa Pharmaceuticals International, plcCL A(KNSA)45,90045,9000$907.9K$1.02M6.50%+$111.5K
BridgeBio Pharma, Inc.(BBIO)40,30026,000-14,300$1.11M$898.8K5.73%-$207.0K
Benitec Biopharma Inc.(BNTC)62,00062,0000$783.1K$806.6K5.15%+$23.6K
Geron Corporation(GERN)500,000500,0000$1.77M$795.0K5.07%-$975.0K
Avadel Pharmaceuticals Plc64,00098,700+34,700$672.6K$772.8K4.93%+$100.2K
Arcutis Biotherapeutics, Inc.(ARQT)46,30046,3000$645.0K$724.1K4.62%+$79.2K
Syndax Pharmaceuticals, Inc.(SNDX)55,00055,0000$727.1K$675.7K4.31%-$51.4K
Jasper Therapeutics, Inc.(JSPR)32,000146,500+114,500$684.2K$630.0K4.02%-$54.2K
Biohaven Ltd.(BHVN)22,70022,7000$847.8K$545.7K3.48%-$302.1K
Disc Medicine, Inc.(IRON)10,60010,6000$672.0K$526.2K3.36%-$145.9K
Milestone Pharmaceuticals Inc.(MIST)1,025,806548,806-477,000$2.42M$439.1K2.80%-$1.98M
REGENXBIO Inc.(RGNX)57,75057,7500$446.4K$412.9K2.63%-$33.5K
Bluebird Bio Inc78,91278,9120$658.1K$385.1K2.46%-$273.0K
Seres Therapeutics, Inc.(MCRB)340,761340,7610$283.2K$238.5K1.52%-$44.6K
Mersana Therapeutics Inc0644,000+644,000$0$221.7K1.41%+$221.7K
Humacyte, Inc.(HUMA)083,500+83,500$0$142.4K0.91%+$142.4K
Spruce Biosciences Inc75,00075,0000$31.5K$21.8K0.14%-$9.7K
Page 1 of 1
Lion Point Capital, LP — 13F Holdings — Q1 2025 | TickerTrail